[ad_1] Steven McIntoshEntertainment reporterGetty ImagesThe closing credits of 2021's No Time To Die, the most recent film in the 007 series, ended with a familiar message: "James Bond will return."But for the last few years,…
Wockhardt, Sun Pharma, Lupin, Alembic Pharma, other pharma…
[ad_1] Pharmaceutical stocks staged a strong rebound on Monday, recovering from last week’s sharp decline after clarity emerged on the scope of fresh US tariffs on imported drugs.Shares of Wockhardt rallied over 10%, leading the…
Trump’s pharma tariffs: Sun Pharma, Cipla to Dr…
[ad_1] Trump's pharma tariffs: In a dramatic development, the US President Donald Trump announced 100% conditional tariffs on the pharma imports from 1st October 2025. The US President made this announcement on Thursday from his…
Zara Larsson hopes ‘Midnight Sun’ helps complete her…
[ad_1] NEW YORK — Zara Larsson is no stranger to packing dance floors around the world, boasting a catalog with several songs that have earned more than a billion streams. But despite possessing all the…
Trump’s 100% tariffs on pharma: Sun Pharma, Biocon,…
[ad_1] Several prominent Indian pharmaceutical firms, including Sun Pharma, Dr. Reddy's Laboratories, Cipla, Lupin, Aurobindo Pharma, and Zydus Lifesciences, maintain substantial export operations to the USA. (AI image) Pharma stocks hit by Trump’s tariffs: Pharmaceutical…
Sun sets on India’s iconic and controversial Soviet…
[ad_1] Soutik BiswasIndia correspondentAFP via Getty ImagesThe MiG‑21 was the backbone of the Indian Air Force, once making up two-thirds of its fighter fleetThe first time he throttled the MiG‑21 to full power, soaring 20km…
Threat of US tariffs hangs over Sun Pharma’s…
[ad_1] Sun Pharmaceutical Industries Ltd expects a limited impact from the US government’s most favoured nation (MFN) drug pricing directive, management told analysts at a meeting last week. The directive requires US agencies to ensure…
Reits are making hay while the sun shines,…
[ad_1] Real estate investment trusts (Reits) are in the limelight following the Securities and Exchange Board of India’s recent decision to reclassify them as equity instruments, a change from their earlier categorization as hybrid instruments.…
Indian equities could hit fresh high in FY26,…
[ad_1] India remains resilient with a strong absorption capacity despite the surge in equity supply. Right now, demand and supply are largely balanced, keeping markets within a narrow range, he explained. “But this is temporary—most…